IRVINE, Calif., June 24, 2015 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. ("Sabra") (Nasdaq:SBRA) today announced the pricing of a previously announced underwritten public offering of 5,900,000 shares of Sabra's common stock, which is expected to result in gross proceeds to Sabra of approximately $149 million. Sabra expects to issue and deliver the shares of its common stock on or about June 30, 2015, subject to customary closing conditions.
Sabra intends to use the net proceeds from the offering to repay borrowings outstanding on Sabra's revolving credit facility. Any remaining proceeds to Sabra will be used to fund possible future acquisitions or for general corporate purposes.
Wells Fargo Securities and J.P. Morgan are acting as joint bookrunning managers for this offering.
The offering is being conducted pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. This press release does not constitute an offer to sell or a solicitation of any offer to buy the shares of Sabra's common stock described herein, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The offering of these securities is being made solely by means of a prospectus supplement and the accompanying prospectus.
Copies of the prospectus supplement and accompanying prospectus for the offering may be obtained by contacting Wells Fargo Securities, Attention: Equity Syndicate Department, 375 Park Avenue, New York, NY 10152, calling (800) 326-5897 or emailing a request to email@example.com or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by calling (866) 803-9204.
CONTACT: Investor & Media Inquiries: (949) 679-0410
Source:Sabra Health Care REIT, Inc.